Koch Matthias, Ehrenreich Tobias, Koehl Gudrun, Pattappa Girish, Pfeifer Christian, Loibl Markus, Müller Michael, Nerlich Michael, Angele Peter, Zellner Johannes
Department of Trauma Surgery, University Medical Center Regensburg, Regensburg, Germany.
Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
Clin Hemorheol Microcirc. 2017;67(2):125-140. doi: 10.3233/CH-17085.
Meniscus regeneration is observed within the peripheral, vascularized zone but decreases in the inner two thirds alongside the vascularization. Within this avascular area, cell-based tissue-engineering-approaches appear to be a promising strategy for the treatment of meniscal defects.
Evaluation of the angiogenic potential of cell-based tissue-engineering-products for meniscus healing.
Evaluation of angiogenesis induced by rabbit meniscus-pellets, meniscus-cells (MC) or mesenchymal stem-cells (MSC) in cell-based tissue-engineering-products within a rabbit meniscus-ring was performed using a transparent dorsal skin fold chamber in nude mice. Observations were undertaken during a 14 days period. Cell preconditioning differed between experimental groups. Immunohistochemical analysis of the regenerated tissue in the meniscus-ring induced by cell loaded composite scaffolds for differentiation and anti-angiogenic factors were performed.
Meniscus-pellets and MSC-/MC-based tissue-engineering-products induced angiogenesis. An accelerated vascularization was detected in the group of meniscus-pellets derived from the vascularized zone compared to avascular meniscus-pellets. In terms of cell-based tissue-engineering-products, chondrogenic preconditioning resulted in significantly increased vessel growth. MSC-constructs showed an accelerated angiogenesis. Immunohistochemical evaluation showed a progressive differentiation and lower content for anti-angiogenic endostatin in the precultured group.
Preconditioning of MC-/MSC-based tissue-engineering-products is a promising tool to influence the angiogenic potential of tissue-engineering-products and to adapt these properties according to the aimed tissue qualities.
半月板再生见于外周血管化区域,但在内侧三分之二区域,随着血管化程度降低而减少。在这个无血管区域,基于细胞的组织工程方法似乎是治疗半月板缺损的一种有前景的策略。
评估基于细胞的组织工程产品促进半月板愈合的血管生成潜力。
使用裸鼠背部透明皮褶小室,评估兔半月板颗粒、半月板细胞(MC)或间充质干细胞(MSC)在基于细胞的组织工程产品中诱导的血管生成情况,这些产品放置在兔半月板环内。观察期为14天。实验组之间细胞预处理方式不同。对负载细胞的复合支架诱导的半月板环内再生组织进行免疫组织化学分析,检测分化和抗血管生成因子。
半月板颗粒以及基于MSC/MC的组织工程产品均可诱导血管生成。与无血管半月板颗粒相比,源自血管化区域的半月板颗粒组检测到血管化加速。就基于细胞的组织工程产品而言,软骨形成预处理导致血管生长显著增加。MSC构建体显示血管生成加速。免疫组织化学评估显示,预培养组中抗血管生成内皮抑素的含量逐渐降低,且有进行性分化。
基于MC/MSC的组织工程产品预处理是一种有前景的工具,可影响组织工程产品的血管生成潜力,并根据目标组织质量调整这些特性。